UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000018839
Receipt No. R000021790
Scientific Title Effects of Ipragliflozin on Body Weight in Japanese Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Insulin Therapy
Date of disclosure of the study information 2015/09/01
Last modified on 2019/04/30 23:11:23

No. Disposal Last modified on Item of update
1 Insert 2015/08/28 10:39:29
2 Update 2015/09/02 13:32:12 Acronym
Acronym
3 Update 2015/09/02 18:11:01 Acronym
Acronym
4 Update 2015/09/02 18:11:48 Randomization unit
5 Update 2016/03/03 09:37:17 Recruitment status
6 Update 2016/09/29 13:41:29 Key secondary outcomes
Key secondary outcomes
7 Update 2016/09/29 13:45:46 Interventions/Control_1
Interventions/Control_1

Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
8 Update 2016/09/29 13:48:27 Last name of lead principal investigator
Name of person sending information
Name of primary sponsor
Organization
9 Update 2016/12/20 17:30:20 Key exclusion criteria
Key exclusion criteria
10 Update 2017/08/30 09:27:31 Organization
Organization
Division name
Division name
11 Update 2018/02/28 17:38:55 Recruitment status
12 Update 2019/04/18 17:15:24 UMIN ID1
13 Update 2019/04/28 19:29:32 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Division name
Division name
Zip code
Address

Last name of contact person

Last name of contact person
Zip code
Address
TEL
Email
Tel1
Email1
Organization
Organization
Address
Address
Tel
Email
Institutions
14 Update 2019/04/28 20:17:34 Date of IRB
Anticipated trial start date
Last follow-up date
Date trial data considered complete
Date analysis concluded
15 Update 2019/04/30 23:07:51 URL releasing protocol
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures
16 Update 2019/04/30 23:11:23 Recruitment status


Contact us.